AI assistant
CEMTREX INC — Board/Management Information 2021
Nov 1, 2021
34786_rns_2021-11-01_ffc61f0a-5933-4f33-ad8b-cd755a695f4b.zip
Board/Management Information
Open in viewerOpens in your device viewer
Field: Rule-Page
Field: /Rule-Page
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): November 1, 2021
Cemtrex Inc.
(Exact name of registrant as specified in its charter)
| Delaware | 001-37464 | 30-0399914 |
|---|---|---|
| (State | ||
| or other jurisdiction of incorporation) | (Commission File | |
| Number) | (I.R.S. | |
| Employer Identification | ||
| No.) |
| 276
| Greenpoint Ave Bld. 8 Suite 208 Brooklyn , NY | 11222 |
|---|---|
| (Address | |
| of principal executive offices) | (Zip |
| Code) |
Registrant’s telephone number, including area code: (631) 756-9116
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| ☐ | Written communications pursuant to Rule 425 under the Securities Act (17CFR 230.425) | | --- | --- | | ☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | | ☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | | ☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☒
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☒
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading symbol | Name of each exchange on which registered | | --- | --- | --- | | Common Stock | CETX | Nasdaq Capital Market | | Series 1 Preferred Stock | CETXP | Nasdaq Capital Market | | Series 1 Warrants | CETXW | Nasdaq Capital Market |
Field: Rule-Page
Field: /Rule-Page
Field: Page; Sequence: 1
Field: /Page
CURRENT REPORT ON FORM 8-K
Cemtrex, Inc.
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Cemtrex, Inc. (the “Company”) has appointed a new independent director and audit committee member, Manpreet Singh, CFA, effective November 1, 2021. Mr. Singh will serve on the Board of Directors (the “Board”) and stand for election for a one-year term at the Annual Shareholder’s Meeting in 2022.
Mr. Singh is the currently the founder and Chief Investment Officer of Singh Capital Partners (SCP), a multifamily office that directs investments into venture capital, real estate, and growth equity. SCP invests capital on behalf of Fortune 500 CXOs, Unicorn founders and operators and has executed investments in North America, Europe and Asia. Prior to founding, SCP, Manpreet was the Co-Founder of TalkLocal - a venture backed local services marketplace. Prior to TalkLocal, Manpreet worked at Profit Investment Management, a DC-based firm, where he was responsible for managing $1B invested in technology companies globally for the firm. He serves on the numerous non-profit and private company boards including AcquCo, US Inspect, Embrace Software, Snowball Industries, Shukr Investments, Suburban Hospital (John Hopkins Medicine) and Dingman Center at the Smith School of Business. He is a CFA Charterholder and Manpreet received his MBA from the Wharton School of Business in Entrepreneurship, Finance, and Real Estate. He also holds a B.S. in Finance with a citation in Entrepreneurship from the University of Maryland, College Park.
Item 9.01 Financial Statements and Exhibits
(d) Exhibits
| Exhibit Number | Exhibit Title | | --- | --- | | 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |
Field: Page; Sequence: 2; Options: NewSection; Value: 2
2
Field: /Page
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| /s/
| Saagar Govil |
|---|
| Saagar |
| Govil |
| Chairman, |
| President and Chief Executive Officer |
Field: Page; Sequence: 3; Options: Last
3
Field: /Page